Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD

被引:6
|
作者
Bathini, Lavanya [1 ,2 ]
Jandoc, Racquel [1 ]
Kuwornu, Paul [1 ]
McArthur, Eric [1 ]
Weir, Matthew A. [1 ,2 ,3 ]
Sood, Manish M. [1 ,4 ]
Battistella, Marisa [5 ]
Muanda, Flory T. [1 ,2 ]
Liu, Aiden [1 ]
Jain, Arsh K. [1 ,2 ,3 ]
Garg, Amit X. [1 ,2 ,3 ]
机构
[1] Inst Clin Evaluat Sci, Toronto, ON, Canada
[2] Western Univ, Dept Med, Div Nephrol, London, ON, Canada
[3] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
[4] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada
[5] Univ Toronto, Fac Pharm, Toronto, ON, Canada
关键词
Aged; 80 and over; cefprozil; Cefuroxime; Anti-Bacterial Agents; Cephalexin; Odds Ratio; glomerular filtration rate; Outpatients; Confidence Intervals; Retrospective Studies; renal dialysis; Cephalosporins; Renal Insufficiency; Chronic; Treatment Failure; Risk; hospitalization; Emergency Service; Hospital; ADVERSE DRUG-REACTIONS; CHRONIC KIDNEY-DISEASE; RISK-FACTORS; PREVALENCE; EQUATION;
D O I
10.2215/CJN.10710918
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Current dosing recommendations for cephalosporin antibiotics are on the basis of pharmacokinetic studies and are frequently ignored in practice. This study was undertaken to investigate the clinical outcomes of failing to dose-reduce cephalosporin antibiotics in CKD. Design, setting, participants, & measurements Retrospective cohort study conducted in Ontario, Canada using linkedpopulation-basedhealthcaredatabases. Nine thousandthreehundred forty-sevenoutpatients (median age 83; interquartile range, 77-88 years; 57% women) with an eGFR, 30 ml/min per 1.73 m2 and no prior history of dialysis were dispensed oral cephalexin, cefuroxime, or cefprozil between April of 2007 andMarch of 2016. Two thirds of the patients (6253 of 9347) received a higher than recommended daily dose of cephalexin (>1000 mg), cefuroxime (>500mg), or cefprozil (>500mg). The primary outcome was a hospital encounter (emergency room visit or hospital admission) with a condition listed as a possible side-effect of cephalosporins. Secondary outcomes were antibiotic treatment failure and all-cause mortality. All measures were assessed in the 30 days after cephalosporin initiation. Results Patients who received a higher than recommended dose of a cephalosporin antibiotic were similar in multiple indicators of baseline health to patientswho received a reduced dose. Overall, 6% of patients presented to hospitalwith a possible cephalosporin side-effect, 13% failed antibiotic treatment, and 3% died. Comparedwith a reduced dose, receiving a higher dose of antibiotic was not associatedwith a different rate of side-effects (adjusted odds ratio, 1.00; 95% confidence interval, 0.84 to 1.20), treatment failure (1.01; 0.88 to 1.15), or death (0.99; 0.76 to 1.29). Conclusions In this study we failed to demonstrate any association between the dose of cephalosporin antibiotic administered to elderly patientswithCKDand the risk of side-effects leading to hospitalization, treatment failure, or mortality.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [41] Outcomes Associated with Inappropriately Dose-Reduced Apixaban in Older Adults with Atrial Fibrillation
    Campbell, A. M.
    Pae, E.
    Lee, E. E.
    Jacisin, T.
    Price, A.
    DeAngelo, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 70 : S35 - S35
  • [42] THE EFFECTIVENESS OF INTERVENTIONS TO REDUCE ADVERSE OUTCOMES AMONG OLDER ADULTS FOLLOWING EMERGENCY DEPARTMENT DISCHARGE
    Conneely, M.
    Leahy, S.
    Dore, L.
    Trepel, D.
    Robinson, K.
    Jordan, F.
    Galvin, R.
    AGE AND AGEING, 2022, 51 (SUPPL 2)
  • [44] Initiation Dose of Allopurinol and the Risk of Severe Cutaneous Reactions in Older Adults With CKD: A Population-Based Cohort Study
    Bathini, Lavanya
    Garg, Amit X.
    Sontrop, Jessica M.
    Weir, Matthew A.
    Blake, Peter G.
    Dixon, Stephanie N.
    McArthur, Eric
    Muanda, Flory T.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (06) : 730 - 739
  • [45] Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults with CKD: A Population-based Cohort Study
    Muanda, Flory T.
    Weir, Matthew A.
    Ahmadi, Fatemeh
    Sontrop, Jessica M.
    Cowan, Andrea
    Fleet, Jamie L.
    Blake, Peter G.
    Garg, Amit X.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (01) : 98 - +
  • [46] IV IRON IN CKD AND HF: IMPROVING CLINICAL OUTCOMES WITH HIGH-DOSE IV IRON IN PATIENTS WITH IRON DEFICIENCY, HEART FAILURE AND CKD
    Kalra, Philip A.
    Ahmed, Fozia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1126 - I1127
  • [47] Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults
    Anderson, Timothy S. S.
    Herzig, Shoshana J. J.
    Jing, Bocheng
    Boscardin, W. John
    Fung, Kathy
    Marcantonio, Edward R. R.
    Steinman, Michael A. A.
    JAMA INTERNAL MEDICINE, 2023, 183 (07) : 715 - 723
  • [48] Clinical presentation, management and outcomes of Staph aureus bacteremia (SAB) in older adults
    Dafna Yahav
    Agata Schlesinger
    Hila Shaked
    Elad Goldberg
    Mical Paul
    Jihad Bishara
    Leonard Leibovici
    Aging Clinical and Experimental Research, 2017, 29 : 127 - 133
  • [49] The use of pulmonary artery catheter and clinical outcomes in older adults with cardiogenic shock
    Watanabe, Atsuyuki
    Miyamoto, Yoshihisa
    Ueyama, Hiroki
    Gotanda, Hiroshi
    Tsugawa, Yusuke
    Kuno, Toshiki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
  • [50] Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults Reply
    Bischoff-Ferrari, Heike A.
    Theiler, Robert
    Molino, Caroline de Godoi Rezende Costa
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (11): : 1112 - 1113